Stocklytics Platform
Asset logo for symbol PFE
Pfizer
PFE60
$23.31arrow_drop_up1.25%$0.28
S&P500
Asset logo for symbol PFE
PFE60

$23.31

arrow_drop_up1.25%
Key Stats
Open$22.95
Prev. Close$23.04
EPS1.41
Next Earnings Date-
LOWHIGH
Day Range22.85
23.38
52 Week Range21.10
33.92
Ratios
EPS1.41
Fundamentals
Industry average yield2.89%
Last Dividend pay dateMar 7, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Analyst rating

An aggregate view of professional's ratings.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Stock Performance

PFE-
US Healthcare Sector-
US Market-
check_circle

PFE / Market

PFE exceeded the US Market which returned 0.03% over the last twenty four hours.
warning

PFE / Healthcare Sector

PFE lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

Pfizer (PFE) Statistics

Pfizer Inc (PFE) is a global pharmaceutical company that develops, manufactures, and markets various healthcare products. As of the writing of this article, the stock is trading at a price of $40.50 per share with a market capitalization of $224.82 billion. With a price-to-earnings (P/E) ratio of 14.85, it indicates that investors are willing to pay $14.85 for every dollar of the company's earnings. The stock has a forward P/E ratio of 11.68, suggesting that analysts expect the company's earnings to grow in the future.
When it comes to valuation metrics, Pfizer Inc has a price-to-sales (P/S) ratio of 3.79, indicating that investors are willing to pay $3.79 for every dollar of the company's revenue. The company's price-to-book (P/B) ratio is 3.29, suggesting that the stock is trading at a premium compared to its book value. Pfizer Inc has a dividend yield of 3.35%, making it an attractive investment for income-seeking investors.
add Pfizer to watchlist

Keep an eye on Pfizer

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Pfizer (PFE) stock's performance compared to its sector and the market over the past year?

Over the past year, Pfizer (PFE) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Pfizer has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Pfizer 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Pfizer (PFE) stock?

The PE (Price to Earnings) ratio of Pfizer (PFE) is currently 16.54. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Pfizer (PFE) stock?

The Earnings Per Share (EPS) for Pfizer (PFE), calculated on a diluted basis, is $1.41. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Pfizer (PFE) stock?

The operating margin for Pfizer (PFE) is 15.9%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Pfizer (PFE) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Pfizer (PFE) is $23.47B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Pfizer (PFE) have?

Pfizer (PFE) has a total debt of $67.42B. The net debt, which accounts for cash and cash equivalents against the total debt, is $62.61B.

Take Your Investments to a Whole New Level